Designed ankyrin repeat proteins: a novel tool for testing epidermal growth factor receptor 2 expression in breast cancer
Open Access
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 23 (9) , 1289-1297
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic ConsiderationsJournal of Clinical Oncology, 2009
- Efficient Selection of DARPins with Sub-nanomolar Affinities using SRP Phage DisplayJournal of Molecular Biology, 2008
- Directed evolution of a G protein-coupled receptor for expression, stability, and binding selectivityProceedings of the National Academy of Sciences, 2008
- Stabilizing Ionic Interactions in a Full-consensus Ankyrin Repeat ProteinJournal of Molecular Biology, 2008
- Characterization and Further Stabilization of Designed Ankyrin Repeat Proteins by Combining Molecular Dynamics Simulations and ExperimentsJournal of Molecular Biology, 2008
- A Designed Ankyrin Repeat Protein Evolved to Picomolar Affinity to Her2Journal of Molecular Biology, 2007
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology, 2007
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Engineering novel binding proteins from nonimmunoglobulin domainsNature Biotechnology, 2005
- Protein detection using proximity-dependent DNA ligation assaysNature Biotechnology, 2002